Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for chemotherapy-induced nausea and vomiting
2007-000444-27Phase 2Terminated
- Sponsor
- Bionorica
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dronabinol in chemotherapy-induced nausea and vomiting (CINV), sponsored by Bionorica. Primary endpoint: Anti-emetic efficacy of different doses of dronabinol. Started Mar 2007; status: terminated.
02
Drugs
dronabinol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2007-000444-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000444-27.